Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Poultry Vaccines Market Forecast: Value Set To Climb From $2.12 Billion To $3.04 Billion#_x000D_
The poultry vaccines market size has demonstrated robust expansion over recent years. Its valuation is projected to increase from $1.94 billion in 2025 to $2.12 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. Historically, this market’s expansion was driven by factors such as outbreaks of avian diseases, an uptick in poultry consumption, advancements in traditional vaccine development, heightened veterinary awareness at the farm level, and the growth of commercial poultry farming._x000D_
_x000D_
The poultry vaccines market size is projected to experience substantial growth in the upcoming years. By 2030, it is anticipated to expand to $3.04 billion, demonstrating a compound annual growth rate (CAGR) of 9.5%. This projected growth during the forecast period can be attributed to the rise of recombinant and DNA vaccines, the adoption of precision poultry vaccination programs, technological advancements in vaccine delivery systems, government initiatives aimed at improving poultry health, and an increasing focus on biosecurity measures within poultry farms. Major trends expected in this period include the increased usage of live and inactivated poultry vaccines, a greater emphasis on disease prevention in broilers and layers, the broader application of recombinant and DNA vaccines, the integration of vaccination programs with broader farm management practices, and the development of robust cold chain infrastructure for poultry vaccine distribution._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Poultry Vaccines Market Demand Drivers: What’s Powering Industry Growth?#_x000D_
The escalating occurrence of zoonotic diseases is anticipated to stimulate the expansion of the poultry vaccine market in the coming period. These common diseases are caused by pathogenic germs such as viruses, bacteria, parasites, and fungi. The growing prevalence of zoonotic diseases is increasing due to heightened human–animal interaction, as expanding urbanization and livestock farming lead to closer contact between people and animals. The poultry vaccine market is bolstered by the rising prevalence of zoonotic diseases, given that elevated disease risks necessitate vaccination to hinder the transmission of infections from poultry to humans and safeguard the health of flocks. For instance, in December 2025, according to European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Therefore, the increasing prevalence of zoonotic diseases is expected to drive the growth of poultry vaccines._x000D_
_x000D_
#Poultry Vaccines Market Segment Performance And Emerging Opportunities#_x000D_
The poultry vaccines market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines_x000D_
2) By Disease Type: Avain Influenza, Infectious Bronchitis _x000D_
3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct_x000D_
4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines_x000D_
5) By Application: Broiler, Layer, Breeder _x000D_
_x000D_
Subsegments:_x000D_
1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines_x000D_
2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines_x000D_
3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines_x000D_
4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines_x000D_
5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines_x000D_
6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines_x000D_
_x000D_
#Poultry Vaccines Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_
Leading companies in the poultry vaccine market are concentrating on developing novel technological solutions to reinforce their market position. These new technological solutions encompass advanced vaccine formulations, sophisticated delivery systems, and improved diagnostic instruments, all designed to enhance disease prevention, efficacy, and overall poultry health management. For example, in October 2023, Zoetis Inc., a US-based animal health company, introduced Circomax. This porcine circovirus type 2 (PCV2) vaccine is available in two genotypes, ‘a’ and ‘b’. The vaccination’s aim is to protect against PCV2 risks, such as the three genotypes observed in the UK pig herd, and to provide broader coverage. This particular PCV2 vaccination is the only one licensed to offer protection against all three genotypes, having demonstrated efficacy against PCV2a, PCV2b, and PCV2d. By launching CircoMax, Zoetis seeks to anticipate the evolution of PCV2 genotypes and to deliver high levels of efficacy, convenience, and proven safety for healthy piglets._x000D_
_x000D_
#Poultry Vaccines Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc. _x000D_
_x000D_
#View The Full Poultry Vaccines Market Report:#_x000D_
_x000D_
#Poultry Vaccines Market Top Region: Where Does Most Revenue Come From?#_x000D_
North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.